Back

Analysis of the current state of acupuncture clinical trial registration and reporting: for the past 9 years

Zhang, Q.; Lv, H.; FU, Y.; Chen, B.; Cai, Y.; Zhang, Q.

2022-05-25 rehabilitation medicine and physical therapy
10.1101/2022.05.21.22275363
Show abstract

BackgroundAn increasing number of acupuncture clinical trials are registered, but the reports of results and data transparency are unclear. We aim to analyze and evaluate the current state of registration and reports of acupuncture clinical trials. MethodsThis paper focused on the acupuncture clinical trials that met the criteria in relevant studies registered and published during the period between 1 Jan 2013 to 31 Dec 2021. We traced by email to leaders that the report could not be searched. Besides, questionnaire investigation was chosen to acupuncture clinicians around by WeChat. ResultsThe overall reporting rate of acupuncture clinical trial results from the two registration centers was 25%. Clinicaltrials.gov reporting rate was 12% and that from ChiCTR was 41%. Only a small proportion of trials were available on the registry website. Only the NIH clinical registry platform has records on the status of studies. We only received 3 replies that indicated the project was due to be ended but not completed. According to questionnaire, 157 clinicians have led clinical projects in Acupuncture. It shows that 84% projects were ended but not completed or not completed by the due date. About the reasons that caused the failure to find articles after the end of the project, 85% participants thought projects were ended but not completed or not completed by the due date. 15% participants thought projects were manuscript rejected, manuscript accepted but not in print, results protected, registration number unmarked, project delayed or negative results not submitted. ConclusionThe number of acupuncture clinical trial registrations is steadily increasing, but the reporting rate of trial results is relatively low and the transparency of data is not ideal. Therefore, first of all, researchers should put more attention on trials designed, trial reported and respect to science. Secondly, set up a research progress tracker on registration platforms accessible to the public users. At the same time, the journal is suggested that adjust the evaluation criteria for reporting the negative results. Researchers with negative results are encouraged to show. Most importantly, the funders are recommended to optimize the ended review.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
BMJ Open
based on 553 papers
Top 8%
13.2%
2
PLOS ONE
based on 1737 papers
Top 45%
11.3%
3
Trials
based on 24 papers
Top 0.2%
7.7%
4
Frontiers in Neurology
based on 74 papers
Top 3%
6.5%
5
Contemporary Clinical Trials Communications
based on 11 papers
Top 0.1%
4.8%
6
Heliyon
based on 57 papers
Top 0.7%
4.6%
7
Journal of Clinical Epidemiology
based on 29 papers
Top 0.5%
4.6%
50% of probability mass above
8
JMIR Research Protocols
based on 18 papers
Top 0.3%
4.6%
9
Medicine
based on 29 papers
Top 2%
3.0%
10
Scientific Data
based on 30 papers
Top 0.5%
2.9%
11
F1000Research
based on 28 papers
Top 0.9%
2.5%
12
Frontiers in Pharmacology
based on 27 papers
Top 2%
2.3%
13
DIGITAL HEALTH
based on 11 papers
Top 0.7%
1.8%
14
Journal of Clinical Medicine
based on 77 papers
Top 9%
1.6%
15
PeerJ
based on 46 papers
Top 5%
1.6%
16
Annals of Translational Medicine
based on 14 papers
Top 2%
1.6%
17
Scientific Reports
based on 701 papers
Top 77%
1.3%
18
Journal of Translational Medicine
based on 21 papers
Top 0.8%
1.3%
19
Healthcare
based on 14 papers
Top 2%
1.3%
20
Journal of NeuroEngineering and Rehabilitation
based on 14 papers
Top 2%
1.3%
21
Nature Communications
based on 483 papers
Top 37%
1.2%
22
International Journal of Environmental Research and Public Health
based on 116 papers
Top 19%
1.2%
23
Brain and Behavior
based on 19 papers
Top 5%
0.7%
24
The Journal of Pain
based on 11 papers
Top 1%
0.7%
25
Neurorehabilitation and Neural Repair
based on 11 papers
Top 2%
0.7%
26
Pilot and Feasibility Studies
based on 12 papers
Top 2%
0.7%
27
Stroke
based on 29 papers
Top 3%
0.7%